e-learning
resources
Berlin 2001
Sunday 23.09.2001
Bronchial carcinoma and mediastinal tumours
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Correlation between clinical and pathological staging in resectable NSCLC - analysis on 360 surgical cases
D. Subotic, D. Mandaric, G. Radosavljevic, V. Cemerikic, L. Andric (Belgrade, Yugoslavia)
Source:
Annual Congress 2001 - Bronchial carcinoma and mediastinal tumours
Session:
Bronchial carcinoma and mediastinal tumours
Session type:
Thematic Poster Session
Number:
885
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Subotic, D. Mandaric, G. Radosavljevic, V. Cemerikic, L. Andric (Belgrade, Yugoslavia). Correlation between clinical and pathological staging in resectable NSCLC - analysis on 360 surgical cases. Eur Respir J 2001; 16: Suppl. 31, 885
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Mediastinal tumours
Should EUS-B be added to EBUS?
The outcome of lymph nodes previously sampled with EBUS-TBNA and deemed "inadequate" - what lessons can be learnt?
Related content which might interest you:
Usefulness of surgical staging after negative EBUS -staging in patients with lung cancer with clinical N0.
Source: International Congress 2019 – General thoracic surgery
Year: 2019
Comparison of clinical and pathological/surgical TNM staging of NSCLC
Source: Eur Respir J 2003; 22: Suppl. 45, 254s
Year: 2003
The relation between clinical tumor stage and metastasis according to sixth TNM staging and new revised TNM staging in non-small lung cancer patients
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010
Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease?
Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018
Year: 2019
Comparative diagnostic accuracy of thoracic endosonography (EBUS/EUS-b) and integrated PET-CT in mediastinal staging of potentially operable patients with NSCLC.
Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound
Year: 2020
Comparative evaluation of resectability, postoperative morbidity and mediastinal downstaging after cisplatin-based chemoinduction versus radiochemoinduction for stage III non-small cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 214s
Year: 2003
Comparison of the new and current TNM staging system in bronchoplastic resection for non-small cell lung cancer
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010
Complete endosonographic nodal staging of lung cancer in patients eligible for stereotactic ablative radiotherapy (STAGE study NCT02997449)
Source: International Congress 2017 – Interventional pulmonology highlights 2017
Year: 2017
Occult N2 disease after surgical resection for clinical stage I NSCLC: factors affecting survival
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009
Survival of patients after complete surgical resection in NSCLC stage IV with solitary metastases
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010
Contribution of FDG-PET on staging and management of NSCLC planned for concomitant chemoradiotherapy
Source: Eur Respir J 2007; 30: Suppl. 51, 664s
Year: 2007
Clinical value of 18-FDG PET-CT in mediastinal lymph node staging in non-small cell lung cancer (NSCLC) patients with previous cN0-1 on CT
Source: Annual Congress 2007 - Diagnosis of thoracic malignancies
Year: 2007
An audit of prognostic significance of histological subtype in surgically resected adenocarcinomas
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Concurrent WBBS and FDG-PET and primary staging of NSCLC, a retrospective analysis
Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities
Year: 2009
Prognostic value of SUVmax in patients with lung cancer who underwent surgical treatment
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012
The comparison of the findings of preoperative PET-CT and surgical pathology in patients with non-small cell lung cancer those with and without induction therapy
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011
Staging and restaging in the era of multimodality treatment
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006
Surgical treatment of lung cancer after polyhemothetapy/radiotherapy down-staging in patients initially assessed as inoperable
Source: Eur Respir J 2006; 28: Suppl. 50, 718s
Year: 2006
Contribution of tumor markers to pretreatment staging of operable lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 360s
Year: 2003
Evaluate of radiological, bronchoscopical and histopathological features of patients with primary lung cancer
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept